UBIVAC, INC.

New Filing
CIK: 0001713945·Biotechnology·DELAWARE·Filed: Aug 26, 2026
Total Offering

Indefinite

Amount Sold

$80,000

Investors

2

First Sale

Aug 2, 2026

Offering Details

Type
Equity, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Bernard Fox, Ph.D.
Hong-Ming Hu, Ph.D.
Bernard A. Fox, III
Sung Poblete, R.N., Ph.D.

Company

UBIVAC, INC.

18183 S.W. BOONES FERRY ROAD

PORTLAND, OR, 97224

503-292-4066

SEC Filing

0001713945-26-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
UBIVAC, INC. Form D Filing — Indefinite | FilingFlow